Company / Net Debt per Share
AVADEL PHARMACEUTICALS PLC Net Debt per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.29
FY2022
5-year range
$0.29 / $1.57
FY2018-FY2022
Trend
-81.3%
vs FY2021
Sector context
#47 of 82
Health Care
What the data says
At $0.29, AVADEL PHARMACEUTICALS PLC's net debt per share ranks #36 of 82 in the Health Care sector. Net Debt per Share has fluctuated over the past 8 years, ranging from $-1.48 in FY2015 to $2.99 in FY2019.
Based on SEC 10-K filings.
0.29 in FY2022 with a 3-year CAGR of -53.9%.
Improved from $1.03 to $0.29 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -53.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#36 of 82 in Health CareTop 43% of 82This company $0.29 Sector average $13.70
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2022, net debt per share decreased 81.3% year-over-year.
- Ranks #47 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2019.
- Lowest net debt per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.29 | -81.3% |
| FY2021 | $1.57 | +52.3% |
| FY2020 | $1.03 | -65.6% |
| FY2019 | $2.99 | +4.8% |
| FY2018 | $2.85 | +831.3% |
| FY2017 | -$0.39 | +58.4% |
| FY2016 | -$0.94 | +36.5% |
| FY2015 | -$1.48 | -38.9% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026